Pharmaceuticals: Major
US companies operating in the same pharmaceuticals: major industry
The table below has US companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Merck & Company, Inc.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 734.92 B USD | 775.45 USD | −2.47% | 4.11 M | 1.28 | 64.24 | 12.07 USD | +80.78% | 0.70% | Health technology | Buy |
 JNJJohnson & Johnson | 366.71 B USD | 152.41 USD | +0.26% | 10.01 M | 1.12 | 16.94 | 9.00 USD | +29.58% | 3.30% | Health technology | Buy |
 ABBVAbbVie Inc. | 322.03 B USD | 182.31 USD | −2.40% | 29.26 M | 5.34 | 77.74 | 2.35 USD | −30.17% | 3.42% | Health technology | Buy |
 NVONovo Nordisk A/SDR | 299.2 B USD | 68.51 USD | +1.20% | 5.63 M | 0.61 | 20.32 | 3.37 USD | +16.43% | 1.75% | Health technology | Buy |
 NVSNovartis AGDR | 228.3 B USD | 120.01 USD | −0.26% | 1.54 M | 1.16 | 18.79 | 6.39 USD | −13.30% | 2.72% | Health technology | Neutral |
 AZNAstraZeneca PLCDR | 215.89 B USD | 69.85 USD | −0.31% | 3.13 M | 0.81 | 28.06 | 2.49 USD | +22.68% | 2.17% | Health technology | Strong buy |
 MRKMerck & Company, Inc. | 198.62 B USD | 79.10 USD | +0.34% | 60.2 M | 3.48 | 11.52 | 6.87 USD | +664.64% | 4.01% | Health technology | Buy |
 PFEPfizer, Inc. | 137.53 B USD | 24.19 USD | −0.21% | 39.53 M | 1.02 | 17.53 | 1.38 USD | — | 7.01% | Health technology | Buy |
 SNYSanofiDR | 117.39 B USD | 47.85 USD | −1.08% | 2.68 M | 1.11 | 19.98 | 2.39 USD | +3.07% | 3.31% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 113.32 B USD | 441.30 USD | −0.47% | 3.62 M | 2.94 | — | −3.92 USD | −125.45% | 0.00% | Health technology | Buy |
 BMYBristol-Myers Squibb Company | 94.33 B USD | 46.35 USD | −0.64% | 21.87 M | 1.46 | 17.40 | 2.66 USD | — | 5.23% | Health technology | Neutral |
 GSKGSK plcDR | 77.49 B USD | 38.58 USD | +0.08% | 4.92 M | 0.89 | 20.03 | 1.93 USD | −29.97% | 4.09% | Health technology | Neutral |
 ZTSZoetis Inc. | 69.53 B USD | 156.17 USD | +0.24% | 2.99 M | 0.96 | 28.04 | 5.57 USD | +7.34% | 1.20% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 56.25 B USD | 521.00 USD | 0.00% | 1.61 M | 1.49 | 13.26 | 39.29 USD | +16.05% | 0.34% | Health technology | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 47.81 B USD | 15.10 USD | +0.27% | 1.54 M | 0.69 | 69.49 | 0.22 USD | −32.20% | 3.89% | Health technology | Buy |
 HLNHaleon plcDR | 46.56 B USD | 10.38 USD | −0.38% | 11.34 M | 0.79 | 25.85 | 0.40 USD | +42.97% | 1.70% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 42.09 B USD | 322.83 USD | +1.44% | 2.05 M | 2.68 | — | −2.09 USD | +21.99% | 0.00% | Health technology | Buy |
 ONCBeOne Medicines Ltd.DR | 33.54 B USD | 241.20 USD | −5.22% | 400.83 K | 1.02 | — | −3.71 USD | +50.93% | 0.00% | Health technology | Strong buy |
 RPRXRoyalty Pharma plc | 20.17 B USD | 35.87 USD | +1.70% | 3.74 M | 0.76 | 14.63 | 2.45 USD | +37.66% | 2.44% | Health technology | Buy |
 INSMInsmed Incorporated | 18.9 B USD | 99.49 USD | −2.21% | 34.49 M | 8.18 | — | −5.95 USD | −13.60% | 0.00% | Health technology | Strong buy |
 BIIBBiogen Inc. | 18.47 B USD | 126.08 USD | −0.66% | 1.1 M | 0.83 | 12.45 | 10.13 USD | +26.48% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 13.23 B USD | 68.37 USD | −3.45% | 3.5 M | 1.80 | 211.54 | 0.32 USD | −90.19% | 0.00% | Health technology | Buy |
 RDYDr. Reddy's Laboratories LtdDR | 12.86 B USD | 15.07 USD | −1.70% | 1.81 M | 1.09 | 18.82 | 0.80 USD | −0.76% | 0.53% | Health technology | Neutral |
 UTHRUnited Therapeutics Corporation | 12.82 B USD | 284.27 USD | +0.06% | 462.93 K | 0.66 | 11.34 | 25.06 USD | +18.48% | 0.00% | Health technology | Buy |
 GMABGenmab A/SDR | 12.72 B USD | 20.50 USD | −1.11% | 727.65 K | 0.36 | 11.63 | 1.76 USD | +46.17% | 0.00% | Health technology | Buy |
 EXELExelixis, Inc. | 11.91 B USD | 43.67 USD | +1.35% | 3.53 M | 0.85 | 19.81 | 2.20 USD | +240.89% | 0.00% | Health technology | Buy |
 VTRSViatris Inc. | 10.57 B USD | 9.01 USD | −1.21% | 17.75 M | 1.57 | — | −3.18 USD | −6,283.33% | 5.26% | Health technology | Neutral |
 ASNDAscendis Pharma A/SDR | 10.44 B USD | 172.22 USD | −0.42% | 255.34 K | 0.63 | — | −6.29 USD | +34.71% | 0.00% | Health technology | Strong buy |
 RGCRegencell Bioscience Holdings Limited | 8.6 B USD | 17.40 USD | −13.82% | 985.99 K | 0.46 | — | — | — | 0.00% | Health technology | — |
 VRNAVerona Pharma plcDR | 8.04 B USD | 93.82 USD | −0.61% | 951.42 K | 0.92 | — | −2.04 USD | −157.53% | 0.00% | Health technology | Strong buy |
 CORTCorcept Therapeutics Incorporated | 7.76 B USD | 73.22 USD | −1.49% | 11.99 M | 11.90 | 63.55 | 1.15 USD | +8.56% | 0.00% | Health technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 7.74 B USD | 11.39 USD | −1.81% | 11.13 M | 1.50 | — | −0.25 USD | −104.91% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 7.31 B USD | 8.86 USD | +0.91% | 477.37 K | 0.60 | 28.80 | 0.31 USD | +1.92% | 0.00% | Health technology | Neutral |
 RGENRepligen Corporation | 6.94 B USD | 123.56 USD | −0.52% | 873.95 K | 1.09 | — | −0.41 USD | −200.76% | 0.00% | Health technology | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 6.68 B USD | 300.75 USD | +0.41% | 540.47 K | 1.73 | — | −18.04 USD | +21.83% | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.47 B USD | 106.90 USD | −0.57% | 871.45 K | 1.31 | 14.42 | 7.42 USD | +61.30% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 6.33 B USD | 39.80 USD | +0.05% | 2.48 M | 1.32 | — | −2.98 USD | −11.81% | 0.00% | Health technology | Buy |
 LEGNLegend Biotech CorporationDR | 6.16 B USD | 34.63 USD | +3.43% | 1.82 M | 0.97 | — | −1.19 USD | +54.33% | 0.00% | Health technology | Strong buy |
 TGTXTG Therapeutics, Inc. | 5.83 B USD | 36.72 USD | −3.24% | 2.47 M | 1.44 | 150.49 | 0.24 USD | +10.66% | 0.00% | Health technology | Strong buy |
 NUVLNuvalent, Inc. | 5.72 B USD | 79.68 USD | +0.70% | 2.07 M | 4.28 | — | −4.40 USD | −82.61% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 4.75 B USD | 28.81 USD | −0.07% | 2.94 M | 1.49 | 13.72 | 2.10 USD | −17.17% | 0.00% | Health technology | Buy |
 AKROAkero Therapeutics, Inc. | 4.48 B USD | 56.19 USD | −0.16% | 3.83 M | 2.09 | — | −3.75 USD | −17.04% | 0.00% | Health technology | Strong buy |
 SLNOSoleno Therapeutics, Inc. | 4.2 B USD | 83.25 USD | −0.92% | 3.28 M | 2.88 | — | −4.62 USD | −72.19% | 0.00% | Health technology | Strong buy |
 PBHPrestige Consumer Healthcare Inc. | 4 B USD | 80.90 USD | −0.31% | 855.8 K | 2.55 | 18.88 | 4.29 USD | +2.73% | 0.00% | Health technology | Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3.99 B USD | 62.73 USD | +2.09% | 858.09 K | 1.58 | — | −2.82 USD | +39.30% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 3.96 B USD | 33.16 USD | −2.21% | 2.35 M | 1.65 | — | −5.31 USD | +1.75% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 3.95 B USD | 49.84 USD | +0.59% | 1.39 M | 1.15 | 7.65 | 6.51 USD | — | 0.00% | Health technology | Buy |
 ACADACADIA Pharmaceuticals Inc. | 3.7 B USD | 22.12 USD | −0.41% | 3 M | 1.41 | 16.10 | 1.37 USD | — | 0.00% | Health technology | Buy |
 PRGOPerrigo Company plc | 3.65 B USD | 26.54 USD | −0.11% | 952.19 K | 0.98 | — | −1.27 USD | −4,006.15% | 4.26% | Health technology | Buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 3.49 B USD | 39.60 USD | −2.96% | 6.73 K | 0.44 | — | −0.75 USD | +59.15% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.45 B USD | 36.52 USD | −1.62% | 2.68 M | 2.76 | — | −5.88 USD | +26.72% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 3.45 B USD | 55.69 USD | +0.86% | 1.55 M | 1.55 | 73.21 | 0.76 USD | −68.94% | 0.00% | Health technology | Strong buy |
 MLTXMoonLake Immunotherapeutics | 3.05 B USD | 47.52 USD | +0.49% | 923.93 K | 2.37 | — | −2.30 USD | −206.92% | 0.00% | Health technology | Strong buy |
 MTSRMetsera, Inc. | 3 B USD | 28.59 USD | −0.42% | 932.26 K | 0.94 | — | — | — | 0.00% | Health technology | Strong buy |
 VKTXViking Therapeutics, Inc. | 2.98 B USD | 26.52 USD | −5.86% | 6.32 M | 1.58 | — | −1.15 USD | −23.84% | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 2.81 B USD | 29.96 USD | −0.10% | 1.64 M | 2.87 | — | −3.82 USD | −1.20% | 0.00% | Health technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 2.69 B USD | 15.10 USD | −1.56% | 37.2 K | 0.48 | 69.88 | 0.22 USD | −62.40% | 0.00% | Health technology | Strong buy |
 CPRXCatalyst Pharmaceuticals, Inc. | 2.66 B USD | 21.78 USD | −0.50% | 2.41 M | 1.70 | 13.90 | 1.57 USD | +191.05% | 0.00% | Health technology | Strong buy |
 OGNOrganon & Co. | 2.56 B USD | 9.86 USD | −1.20% | 4.46 M | 1.28 | 3.41 | 2.89 USD | −29.15% | 8.62% | Health technology | Neutral |
 AMRXAmneal Pharmaceuticals, Inc. | 2.55 B USD | 8.13 USD | 0.00% | 2.57 M | 1.37 | — | −0.04 USD | +92.15% | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 2.53 B USD | 51.09 USD | +1.05% | 939.54 K | 2.20 | — | −1.61 USD | +57.12% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 2.49 B USD | 32.40 USD | +0.62% | 13.15 M | 15.39 | — | −3.22 USD | −18.58% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 2.38 B USD | 2.70 USD | −3.23% | 15.46 M | 2.01 | — | −0.58 USD | +44.53% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 2.2 B USD | 114.15 USD | −1.33% | 327.87 K | 2.36 | — | −7.12 USD | −233.81% | 0.00% | Health technology | Strong buy |
 BGMBGM Group Ltd. | 2.2 B USD | 11.97 USD | −6.63% | 86.26 K | 0.70 | — | −0.20 USD | +81.70% | 0.00% | Health technology | — |
 APLSApellis Pharmaceuticals, Inc. | 2.19 B USD | 17.43 USD | −5.27% | 3.83 M | 2.52 | — | −1.79 USD | +48.16% | 0.00% | Health technology | Buy |
 VCELVericel Corporation | 2.1 B USD | 41.73 USD | +0.17% | 1.13 M | 2.70 | 1,056.46 | 0.04 USD | — | 0.00% | Health technology | Strong buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2.08 B USD | 18.57 USD | +0.65% | 1.24 M | 1.23 | — | −1.88 USD | −1,314.68% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 2.05 B USD | 28.04 USD | −1.58% | 8.69 M | 12.30 | — | −0.24 USD | −324.19% | 0.00% | Health technology | Strong buy |
 BLTEBelite Bio, IncDR | 1.95 B USD | 59.04 USD | −1.44% | 31.5 K | 0.78 | — | −1.36 USD | −15.56% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.94 B USD | 33.47 USD | −0.53% | 489.99 K | 0.83 | 2.97 | 11.29 USD | — | 0.00% | Health technology | Buy |
 IDYAIDEAYA Biosciences, Inc. | 1.87 B USD | 21.37 USD | −4.13% | 3.2 M | 3.30 | — | −3.59 USD | −79.25% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1.84 B USD | 31.98 USD | +0.38% | 1.45 M | 2.26 | 12.19 | 2.62 USD | +13.25% | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 1.83 B USD | 5.93 USD | +4.22% | 9.95 M | 1.64 | — | −0.09 USD | +80.86% | 0.00% | Health technology | Strong buy |
 SPRYARS Pharmaceuticals, Inc. | 1.79 B USD | 18.20 USD | +0.66% | 3.88 M | 2.62 | — | −0.16 USD | +68.69% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1.74 B USD | 31.16 USD | −0.13% | 1.1 M | 1.39 | 28.21 | 1.10 USD | — | 0.00% | Health technology | Buy |
 CNTACentessa Pharmaceuticals plcDR | 1.74 B USD | 13.13 USD | +0.69% | 817.53 K | 0.71 | — | −1.80 USD | −26.97% | 0.00% | Health technology | Strong buy |
 INDVIndivior PLC | 1.74 B USD | 13.95 USD | +1.90% | 20.72 M | 24.41 | — | −0.23 USD | −1,980.17% | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 1.7 B USD | 40.35 USD | +0.05% | 951.83 K | 1.46 | — | −2.73 USD | +42.86% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 1.68 B USD | 17.11 USD | −0.70% | 4.73 M | 0.41 | — | −2.58 USD | −3,975.64% | 0.00% | Health technology | Buy |
 ARQTArcutis Biotherapeutics, Inc. | 1.64 B USD | 13.74 USD | −4.58% | 2.34 M | 1.13 | — | −1.04 USD | +64.22% | 0.00% | Health technology | Strong buy |
 EVOEvotec SEDR | 1.49 B USD | 4.16 USD | −1.42% | 78.98 K | 0.56 | — | −0.63 USD | −125.61% | 0.00% | Health technology | Buy |
 OCULOcular Therapeutix, Inc. | 1.47 B USD | 9.22 USD | −2.54% | 4.21 M | 1.92 | — | −1.15 USD | +15.26% | 0.00% | Health technology | Strong buy |
 ETNB89bio, Inc. | 1.44 B USD | 9.86 USD | −0.90% | 3.98 M | 1.75 | — | −3.38 USD | −68.13% | 0.00% | Health technology | Strong buy |
 BHVNBiohaven Ltd. | 1.44 B USD | 14.09 USD | −4.41% | 2.91 M | 1.34 | — | −9.37 USD | −37.00% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 1.31 B USD | 14.77 USD | −2.38% | 4.1 M | 2.70 | — | −2.80 USD | +44.52% | 0.00% | Health technology | Strong buy |
 INVAInnoviva, Inc. | 1.25 B USD | 19.96 USD | −2.11% | 3 M | 3.01 | — | −1.00 USD | −144.70% | 0.00% | Health technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 1.21 B USD | 21.08 USD | 0.00% | 383.07 K | 0.48 | — | −2.58 USD | −11.34% | 0.00% | Health technology | Strong buy |
 VRDNViridian Therapeutics, Inc. | 1.17 B USD | 14.33 USD | −1.51% | 1.28 M | 1.70 | — | −4.05 USD | +10.13% | 0.00% | Health technology | Strong buy |
 MNKDMannKind Corporation | 1.14 B USD | 3.76 USD | −0.27% | 9.46 M | 2.99 | 37.71 | 0.10 USD | +322.46% | 0.00% | Health technology | Strong buy |
 HROWHarrow, Inc. | 1.13 B USD | 30.88 USD | −1.50% | 463.6 K | 1.38 | — | −0.61 USD | +33.18% | 0.00% | Health technology | Strong buy |
 LQDALiquidia Corporation | 1.12 B USD | 13.10 USD | +2.10% | 2.09 M | 0.98 | — | −1.56 USD | +0.26% | 0.00% | Health technology | Strong buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 1.09 B USD | 23.08 USD | −0.43% | 1.27 M | 2.83 | 8.38 | 2.76 USD | −5.04% | 0.00% | Health technology | Buy |
 PCRXPacira BioSciences, Inc. | 1.09 B USD | 23.48 USD | −0.97% | 685.01 K | 1.38 | — | −2.29 USD | −264.46% | 0.00% | Health technology | Buy |
 OCSOculis Holding AG | 1.06 B USD | 19.35 USD | −0.67% | 10.1 K | 0.41 | — | −2.65 USD | −43.02% | 0.00% | Health technology | Strong buy |
 PAHCPhibro Animal Health Corporation | 1.04 B USD | 25.66 USD | +2.15% | 741.66 K | 3.26 | 32.83 | 0.78 USD | +140.54% | 1.91% | Health technology | Neutral |
 COLLCollegium Pharmaceutical, Inc. | 962.02 M USD | 29.93 USD | +0.10% | 315.47 K | 0.99 | 24.67 | 1.21 USD | −49.45% | 0.00% | Health technology | Strong buy |
 AKBAAkebia Therapeutics, Inc. | 958.62 M USD | 3.65 USD | −2.41% | 8.51 M | 1.75 | — | −0.22 USD | +2.76% | 0.00% | Health technology | Strong buy |
 PHVSPharvaris N.V. | 926.38 M USD | 17.00 USD | −5.03% | 33.52 K | 1.85 | — | −3.02 USD | −18.08% | 0.00% | Health technology | Strong buy |
 SYRESpyre Therapeutics, Inc. | 918.58 M USD | 15.22 USD | −4.99% | 2.21 M | 3.35 | — | −3.03 USD | +94.51% | 0.00% | Health technology | Strong buy |